■ 学術雑誌
|
原著
|
|
1.
|
里井 壯平, 本田 五郎, 松本 晃太郎, 小妻 幸男, 富安 真二朗, 今井 克憲, 林 洋光, 橋本 大輔, 東 賢剛, 副島 秀久, 角田 圭雄：
膵切除術における外科的アプローチ別の収支損益分析.
日本消化器外科学会雑誌
58
(5)
：249
-258
, 2025
|
|
2.
|
Mii Satoshi, Yamaki So, Hashimoto Daisuke, Matsumura Kazuki,Ishida Hiroyuki, Miyazaki Hidetaka, Matsui Yuki, Ikeda Yuji, Ikeura Tsukasa, Satoi Sohei：
Emergency Cholecystectomy in Patients Classified as High Risk According to the Tokyo Guidelines 2018: A Real-World Analysis.
Annals of Gastroenterological Surgery
10
(4)
：1298
-1308
, 2026
|
|
3.
|
Yuki Matsui, Daisuke Hashimoto, So Yamaki, Kazuki Matsumura, Hidetaka Miyazaki, Yuji Ikeda, Denys Tsybulskyi, Thanh Sang Nguyen, Sohei Satoi：
A history of gastrectomy is a risk factor for choledocholithiasis in patients undergoing cholecystectomy: A single center retrospective study.
Annals of gastroenterological surgery
9
(5)
：1047
-1054
, 2025
|
|
4.
|
Rangelova E, Stoop TF, van Ramshorst TME, Ali M, van Bodegraven EA, Javed AA,
Hashimoto D, Steyerberg E, Banerjee A, Jain A, Sauvanet A, Serrablo A, Giani A,
Giardino A, Zerbi A, Arshad A, Wijma AG, Coratti A, Zironda A, Socratous A,
Rojas A, Halimi A, Ejaz A, Oba A, Patel BY, Björnsson B, Reames BN, Tingstedt B,
Goh BKP, Payá-Llorente C, Domingo Del Pozo C, González-Abós C, Medin C, van
Eijck CHJ, de Ponthaud C, Takishita C, Schwabl C, Månsson C, Ricci C, Thiels CA,
Douchi D, Hughes DL, Kilburn D, Flanking D, Kleive D, Sousa Silva D, Edil BH,
Pando E, Moltzer E, Kauffman EF, Warren E, Bozkurt E, Sparrelid E, Thoma E,
Satoi S; European Consortium on Minimally
Invasive Pancreatic Surgery (E-MIPS) and the International Consortium on
Advanced Pancreatic Surgery.：
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study.
Annals of oncology
36
(5)
：529
-542
, 2025
|
|
5.
|
Suzuki S, Omori Y, Ono Y, Hirose K, Itoh T, Karasaki H, Shimoda M, Nagakawa
Y, Higuchi R, Endo I, Rikiyama T, Unno M, Fujii T, Sunagawa Y, Eguchi H,
Sasanuma H, Akahori T, Okano K, Tani M, Hirano S, Shimizu Y, Kitago M, Mizuno S,
Yamamoto T, Furukawa M, Ohtsuka M, Sugimoto M, Matsushita A, Hakamada K,
Igarashi H, Kuroki T, Tanno S, Tsuji Y, Masamune A, Mizumoto K, Hirooka Y,
Yamaue H, Okazaki K, Satoi S, Takeyama Y, Mizukami Y, Furukawa T.：
Three Molecular Developmental Pathways of Remnant Pancreatic Cancer after Resection: A Nationwide Project Study of Japan Pancreas Society.
Annals of surgery
281
(6)
：1015
-1025
, 2025
|
|
6.
|
Unno M, Motoi F, Matsuyama Y, Satoi S, Toyama H, Matsumoto I, Aosasa S,
Shirakawa H, Wada K, Fujii T, Yoshitomi H, Takahashi S, Sho M, Ueno H, Kosuge T.：
Neoadjuvant Chemotherapy with Gemcitabine and S-1 versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.
Annals of surgery
283
(1)
：57
-64
, 2026
|
|
7.
|
Kazuto Shibuya, Joon Seong Park, Wooil Kwon, Manabu Kawai, Isaku Yoshioka, Daisuke Hashimoto, Hideki Takami, Chang-Sup Lim, Hyung Il Seo, Minako Nagai, Yosuke Inoue, Yoo-Seok Yoon, Seung Eun Lee, Hideo Baba, Sae Byeol Choi, Hyeon Kook Lee, Jae Do Yang, Yasutoshi Kimura, Ho Kyoung Hwang, Yang Won Nah, Masaji Tani, Keiichi Akahoshi, In Woong Han, Yuichi Nagakawa, Hidetoshi Eguchi, Suguru Yamada, Sohei Satoi, Masayuki Sho, Megumi Kitayama, Ke Wan, Toshio Shimokawa, Hiroki Yamaue, Jin-Young Jang, Tsutomu Fujii：
Effect of Double Layer Polyglycolic Acid Felt for Reducing Pancreatic Fistula After Pancreatoduodenectomy: Results of a Multicenter Randomized Control Trial (PLANET-PJ trial).
Annals of surgery
283
(3)
：398
-409
, 2026
|
|
8.
|
Satoshi Yasuda, Sohei Satoi, Hideki Takami, Satoshi Hirano, Hirofumi Akita, Yu Takahashi, Yuta Yoshida, Michiaki Unno, Riki Ninomiya, Manabu Kawai, Yuichi Nagakawa, Teiichi Sugiura, Naoto Yamamoto, Minako Nagai, Kenichiro Uemura, Masafumi Imamura, Naoki Ozu, Masafumi Nakamura, Masayuki Otsuka, Masayuki Sho：
Clinicopathological Factors on Survival after Conversion Surgery for Unresectable Locally Advanced Pancreatic Cancer: A Nationwide Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Annals of surgery
：Online ahead of print
, 2026
|
|
9.
|
Urban Arnelo, Roberto Valente, Marc G Besselink, Christian Max Schmidt, Stuart Sherman, Guduru Venkat Rao, Richard A Burkhart, Yi Miao, Sohei Satoi, Rogier P Voermans, Shreeyash Modak, Steven Edmundowicz, Olivier R Busch, Kelly J Lafaro, Jishu Wei, Joyce A Peetermans, Matthew J Rousseau, Marco Del Chiaro,：
Value of Intraoperative Pancreatoscopy in Patients Undergoing Resection for Main-Duct Intraductal Papillary Mucinous Neoplasm: Thirty-Day Follow-Up of a Prospective International Study.
Annals of surgery open : perspectives of surgical history, education, and clinical approaches
7
(1)
：e638
, 2026
|
|
10.
|
Takashi Murakami, Ryusei Matsuyama, Masanori Oshi, Yasuhiro Yabushita, Masayuki Sho, Michiaki Unno, Shuji Isaji, Goro Honda, Suguru Yamada, Satoshi Hirano, Sohei Satoi, Masayuki Ohtsuka, Yoshiaki Murakami, Hiroki Yamaue, Takukazu Nagakawa, Tetsuo Ohta, Itaru Endo：
Comparison between Neoadjuvant Chemoradiotherapy and Chemotherapy for Patients with Resectable Pancreatic Cancer.
Annals of surgical oncology
：Online ahead of print
, 2025
|
|
11.
|
Yuya Ashitomi, Fuyuhiko Motoi, Atsushi Oba, Teiichi Sugiura, Daisuke Hashimoto, Koetsu Inoue, Kenjiro Okada, Hideki Takami, Toru Nakamura, Ryosuke Takahashi, Keiichi Akahoshi, Kimitaka Tanaka, Hideki Ishikawa, Kojiro Omiya, Katsuhisa Ohgi, So Yamaki, Masamichi Mizuma, Kenichiro Uemura, Shuichiro Sugawara, Satoshi Hirano, Sohei Satoi,：
Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer.
Annals of surgical oncology
：Online ahead of print
, 2025
|
|
12.
|
Kazuyoshi Yamamoto, Yukinori Kurokawa, Satoshi Hattori, Yoshiro Yukawa, Takeshi Omori, Ryota Matsui, Daisuke Ichikawa, Yoshitomo Yanagimoto, Takashi Oshima, Takashi Kamei, Hiroya Takeuchi, Yoshihiro Nabeya, Masaki Kaibori, Naoki Hiki, Hidetoshi Eguchi, Yuichiro Doki：
Defining Low Muscle Mass in Cancer Patients: Sex-Specific Computed Tomography-Derived Cutoff Values and Survival Impact-A Multicenter Cohort Study.
Annals of surgical oncology
：Online ahead of print
, 2025
|
|
13.
|
Thomas F Stoop, Y H Andrew Wu, Atsushi Oba, Mahsoem Ali, Isabel M Feld, Mohammed H Al-Musawi, Ajay Jain, Akio Saiura, Alain Sauvanet, Alessandro Coppola, Ammar A Javed, Bas Groot Koerkamp, Braden N Miller, Daisuke Hashimoto, Damiano Caputo, Dyre Kleive, Elisabetta Sereni, Geert Kazemier, Giulio Belfiori, Hirofumi Ishida, Jacob L van Dam, Jeanne Dembinski, Keiichi Akahoshi, Keith J Roberts, Kimitaka Tanaka, Knut J Labori, Massimo Falconi, Michael G House, Motokazu Sugimoto, Minoru Tanabe, Naoto Gotohda, Nikolaos Chatzizacharias, Paul S Krohn, Safi Dokmak, Salvador Rodriguez Franco, Satoshi Hirano, Stefan K Burgdorf, Stefano Crippa, Sohei Satoi, Trang K Nguyen, Tomohisa Yamamoto, Toru Nakamura, Yuta Ushida, Vismaya Bachu, William R Burns, Yosuke Inoue, Yu Takahashi, Zohra Aslami, Richard D Schulick, Jin He, Wells Messersmith, Marc G Besselink, Richard A Burkhart, Johanna W Wilmink, Marco Del Chiaro,：
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study.
British journal of cancer
133
(1)
：76
-84
, 2025
|
|
14.
|
Ikeda M, Okusaka T, Ueno M, Ozaka M, Satoi S, Skanji D, Martín-Fernández L,
Amellal N, Furuse J.：
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial design.
Future oncology
21
(8)
：959
-965
, 2025
|
|
15.
|
Ayaka Takaori, Tsukasa Ikeura, Daisuke Hashimoto, Motonobu Maruo, Masatoshi Ikeda, Takashi Ito, Koh Nakamaru, Masataka Masuda, Shinji Nakayama, Hidetaka Miyazaki, Kazuki Matsumura, So Yamaki, Tomoyo Yasuda, Masashi Kanai, Shohei Akagawa, Shoji Tsuji, Koichiro Higasa, Sohei Satoi, Makoto Naganuma：
Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer.
Gastro hep advances
5
(1)
：100779
, 2025
|
|
16.
|
Kien Vu Trung, Einas Abou-Ali, Aiste Gulla, Kevin Soares, Fabrice Caillol, Woo H Paik, Bertrand Napoleon, Asif Halimi, Viliam Masaryk, Marco J Bruno, Enrique Pérez-Cuadrado-Robles, Louisa Bolm, Steffen Seyfried, Maria C Petrone, Bengisu Yilmaz, Charles Vollmer, Arthur Berger, Laura Maggino, Peter Schemmer, Dörte Wichmann, Elias Karam, Ana Dugic, Lumir Kunovsky, Sara Regner, Sebastien Gaujoux, Marcus Hollenbach, ; Study group:Sohei Satoi 80：
Development and Validation of the SDLD-Score: a Simplified Tool to Predict Successful Endoscopic Papillectomy in Ampullary Lesions.
Gastrointestinal endoscopy
102
(4)
：602
-606
, 2025
|
|
17.
|
Ishida H, Stoop TF, Oba A, Bachellier P, Ban D, Endo I, Franklin O, Fujii T,
Gulla A, Hackert T, Halimi A, Hirano S, Jang JY, Katz MHG, Maekawa A, Nealon WH,
Perri G, Ramia JM, Rompen IF, Satoi S, Schulick RD, Shrikhande SV, Tsung A,
Wolfgang CL, Besselink MG, Del Chiaro M; Americas Hepato-Pancreato-Biliary
Association; Asian-Pacific Hepato-Pancreato-Biliary Association; Scientific and
Research Committee of European-African Hepato-Pancreato-Biliary Association;
European Pancreatic Club; Pancreas Club; Japanese Society of Hepato-Biliary-
Pancreatic Surgery; Korean Association of Hepato-Biliary-Pancreatic Surgery;
International Collaborative Group on Locally Advanced Pancreatic Cancer;
International Hepato-Pancreato-Biliary Association; Collaborators.：
Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvement.
HPB
27
(7)
：910
-921
, 2025
|
|
18.
|
Yuko Suzuki, Masafumi Ikeda, Junki Mizusawa, Yusuke Sano, Chigusa Morizane, Takuji Okusaka, Satoshi Kobayashi, Hiroshi Imaoka, Takeshi Terashima, Naohiro Okano, Haruo Miwa, Akiko Todaka, Satoshi Shimizu, Nobumasa Mizuno, Sohei Satoi, Keiji Sano, Kazutoshi Tobimatsu, Akio Katanuma, Masato Ozaka, Makoto Ueno：
Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113.
International journal of clinical oncology
30
(10)
：2053
-2062
, 2025
|
|
19.
|
Fukushi K, Imaoka H, Ikeda M, Mizusawa J, Morizane C, Okusaka T, Kobayashi S,
Sasahira N, Shimizu S, Yamazaki K, Okano N, Miwa H, Hara K, Satoi S, Sano K,
Sakai K, Sugimoto R, Nakamura K, Terashima T, Ozaka M, Ueno M; JCOG
Hepatobiliary and Pancreatic Oncology Group.：
Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113.
Japanese journal of clinical oncology
55
(4)
：355
-361
, 2025
|
|
20.
|
Okada M, Suzuki E, Morizane C, Ogawa G, Sano Y, Imaoka H, Kobayashi S, Ikeda
M, Okano N, Miwa H, Todaka A, Shimizu S, Mizuno N, Satoi S, Sano K, Tobimatsu K,
Katanuma A, Masutomi K, Okusaka T, Ozaka M, Ueno M; members of the Hepatobiliary
and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).：
Impact of clinically diagnosed liver cirrhosis in patients with intrahepatic cholangiocarcinoma treated with systemic chemotherapy: a subgroup analysis of JCOG1113.
Japanese journal of clinical oncology
55
(6)
：594
-602
, 2025
|
|
21.
|
Kohei Nakata, Yoshihiro Miyasaka, Takeaki Ishizawa, Masayuki Ohtsuka, Masamichi Mizuma, Sohei Satoi, Masaaki Hidaka, Shuji Suzuki, Hiroshi Kurahara, Chie Kitami, Satoshi Hirano, Dongha Lee, Saiho Ko, Munenori Tahara, Isaku Yoshioka, Kenjiro Date, Kazuyuki Nagai, Goro Honda, Shugo Mizuno, Kenichi Hakamada, Yasuro Futagawa, Shigeru Marubashi, Hiroshi Yoshida, Akihiko Horiguchi, Yasuo Hosouchi, Masafumi Imamura, Naoto Gotohda, Hiroaki Nagano, Masaji Tani, Takeshi Sudo, Teijiro Hirashita, Junichi Arita, Katsutoshi Murase, Ken Fukumitsu, Toshiki Rikiyama, Teruyuki Usuba, Toshiya Abe, Masafumi Nakamura, Itaru Endo：
Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: A Multicenter National Cohort Study.
Journal of hepato-biliary-pancreatic sciences
32
(8)
：611
-619
, 2025
|
|
22.
|
Denys Tsybulskyi, Daisuke Hashimoto, Kimitaka Tanaka, Kenta Murotani, Masataka Taguri, So Yamaki, Shoki Sato, Atsushi Oba, Yosuke Inoue, Shimpei Otsuka, Katsuhisa Ohgi, Teiichi Sugiura, Ryuta Shintakuya, Kenjiro Okada, Kenichiro Uemura, Koetsu Inoue, Masamichi Mizuma, Michiaki Unno, Toshimichi Asano, Nobuhiko Nakagawa, Hideki Takami, Ryosuke Takahashi, Fuyuhiko Motoi, Keiichi Akahoshi, Daisuke Ban, Aiste Gulla, Hideki Ishikawa, Satoshi Hirano, Sohei Satoi,：
Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model.
Journal of hepato-biliary-pancreatic sciences
33
(3)
：216
-227
, 2026
|
|
23.
|
Haruyoshi Tanaka, Kenichi Hirabayashi, Tsutomu Fujii, Nobuyuki Ohike, Makoto Ueno, Takahiro Mizui, Masaharu Ishida, Shinichi Egawa, Toru Furukawa, Yuichi Nagakawa, Takao Itoi, Hirohisa Kitagawa, Yohei Masugi, Masaji Tani, Noriyoshi Fukushima, Takashi Hatori, Yosuke Tajika, Sohei Satoi, Michiaki Unno, Yoshifumi Takeyama：
Clinical importance of suspicious for malignancy compared to positive for malignancy in peritoneal cytology for surgically resected pancreatic cancer.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
25
(4)
：544
-551
, 2025
|
|
24.
|
Nana Kimura, Yoshihiro Shirai, Ayaka Itoh, Katsuhisa Hirano, Kazuto Shibuya, Kenta Murotani, Makoto Ueno, Sohei Satoi, Hiroaki Nagano, Junji Furuse, Yoshifumi Takeyama, Tsutomu Fujii,：
A multicenter prospective study to determine the optimal range of lymph node dissection in pancreatic cancer surgery after neoadjuvant chemotherapy (LYMRIN-Trial): Project study by the Japan Pancreas Society and JON 2302-P.
PloS one
20
(6)
：e0325667
, 2025
|
|
25.
|
Yuki Matsui, Daisuke Hashimoto, Nobuhiko Nakagawa, So Yamaki, Masamichi Hayashi, Hideki Takami, Kazuto Shibuya, Suguru Yamada, Sohei Satoi, Tsutomu Fujii：
Long-term outcomes of prophylactic right-half dissection of the superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: five-year results from a randomized phase II trial.
Surgery today
55
(11)
：1562
-1571
, 2025
|
|
総説及び解説
|
|
1.
|
D-Y Oh, B Shen, S Satoi, J Zhou, K-P Kim, S P Choo, S M Woo, S L Chan, L Shen, M Ikeda：
Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia.
ESMO gastrointestinal oncology
8
：100158
, 2025
|
|
2.
|
Carl-Stephan Leonhardt, Mustapha Adham, Shouki Bazarbashi, Irit Ben-Aharon, Regina G H Beets-Tan, Ugo Boggi, Thomas B Brunner, Francesco Cellini, Arturo Chiti, Lois Daamen, Berardino De Bari, Sara De Dosso, Michel Ducreux, Cathy Eng, Massimo Falconi, Cristina R Ferrone, Isabella Frigerio, Ingrid Garajova, Sabine Gerum, Michael Ghadimi, Thomas Gruenberger, Pascal Hammel, Karin Haustermans, Maria Hawkins, Jin He, Hanne D Heerkens, Florence Huguet, Martijn P W Intven, Ulla Klaiber, Tiuri E Kroese, Pierre Laurent-Puig, Florian Lordick, Ethan B Ludmir, Teresa Macarulla, Oscar Matzinger, Alessio G Morganti, Somnath Mukherjee, Eileen M O'Reilly, Joon Oh Park, Demetris Papamichael, Per Pfeiffer, José M Ramia, Falk Roeder, Erika Ruiz-García, Sohei Satoi, et al.：
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.
The Lancet. Oncology
27
(3)
：e141
-e149
, 2026
|
|
その他
|
|
1.
|
橋本 大輔, 山木 壮, 松村 和季, 宮崎 秀高, 松井 雄基, 池田 裕二, Tsybulskyi Denys, Nguyen Thanh Sang, 里井 壯平：
【肝腫瘍の外科治療戦略(肝細胞癌・肝内胆管癌・大腸癌肝転移以外)】転移性肝腫瘍 膵癌肝転移に対する外科的治療戦略.
外科
87
(6)
：697
-702
, 2025
|
|
2.
|
三井哲史、松島英之、木口剛造、小坂久、山本栄和、松井康輔、海堀昌樹：
「消化器癌周術期におけるONSのエビデンスと意義」肝胆膵.
外科と代謝･栄養
59
(4)
：100
-104
, 2025
|
|
3.
|
島谷 昌明, 松本 浩尚, 折野 匡洋, 豊永 啓翔, 加納 真孝, 弓場 孝郁, 中川 達矢, 高山 拓也, 高山 昇之, 岡 新, 賀嶋 隆人, 津留 和紗, 城 直輝, 松野 好樹, 吉岡 優希, 関 泰志, 北出 浩章, 正木 誠人, 小杉 隆：
【ERCPトラブルシューティングを極める】バルーン小腸内視鏡下ERCPにおけるトラブルシューティング 胆管・膵管空腸吻合部狭窄症例における困難例に対するトラブルシューティング 胆管・膵管空腸吻合部の同定や挿管が困難な際にどうする?【動画付】.
胆と膵
46
(臨増特大)
：1321
-1328
, 2025
|
|
4.
|
橋本 大輔, 山木 壮, 里井 壯平：
治療法の再整理とアップデートのために 専門家による私の治療 膵神経内分泌腫瘍(pNET).
日本医事新報
(5309)
：30
-32
, 2026
|
|
5.
|
山木 壮, 橋本 大輔, 里井 壯平：
【よくわかる膵体尾部切除術】脾温存膵体尾部切除術 低侵襲手術時代における開腹脾温存膵体尾部切除術.
臨床外科
80
(7)
：826
-829
, 2025
|
|
6.
|
Takao Ohtsuka, Daisuke Hashimoto, Franz Apodaca Torrez：
Defining oligo-recurrence criteria for locoregional intervention in pancreatic ductal adenocarcinoma: A multidisciplinary era perspective.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
25
(6)
：815
-816
, 2025
|
|
7.
|
Emelie Nébel, Lätitia Dennin, Johannes Klose, Ulrich Ronellenfitsch, Jörg Kleeff, Artur Rebelo, Young Surgeons Publications Committee(Patrick S Plum, Martina Nebbia, Thomas F Stoop, Mara R Goetz, Lena Conradi, Nathanael Raschzok, Hannes Jansson, Patrik Larsson, Sarah Gerber, Jorge Roldàn, Theodoros Michelakos, Benedict Kinny-Köster, Ingmar F Rompen, Oskar Franklin, Ioannis A Ziogas, Hiroyuki Ishida, Andrii Khomiak, Daisuke Hashimoto, Vincent P Groot, Y H Andrew Wu, Toshitaka Sugawara, Atsushi Oba, Aya Maekawa, Jelmer E Oor, Alessio Morandi, David B Stewart, Nicholas Joseph Zyromski, Matthias Ilmer, Ibrahim Büdeyri, Artur Rebelo, Constantin Scholz, Elisa Bannone, Krishna Kotecha, Adisa Poljo)：
Call for participation in a multicenter study: Intraoperative blood loss - Towards a standardized and objective recording method.
Surgery open science
27
：110
-112
, 2025
|
|
8.
|
Nicolas Jorek, Ingmar F Rompen, Louisa Bolm, Thomas Hank, Martin Loos, Christoph W Michalski, Nerma Crnovrsanin,( Daisuke Hashimoto et al.)：
Liquid biopsies for risk stratification of intraductal papillary mucinous neoplasms.
Surgery open science
28
：34
-35
, 2025
|
|
■ 学会発表
|
国際学会及び海外の学会
|
|
1.
|
◎Sohei Satoi：
Advances in surgical management of PNET.
KDDW/Korean Pancreatobiliary Association,
Seoul, South Korea,
2025/11
|
|
2.
|
◎Hirano, Hidetaka Miyazaki, Daisuke Hashimoto, So Yamaki, Hiroyuki Ishida, Kazuki Matsumura, Yuki Matsui, Yuji Ikeda, Sohei Satoi.：
New Pathological Response System; Regression Pattens For Resectable/ Borderline Resectable Pancreatic cancers.
Annual Congress of KSS 2025 & 77th Congress of theKorean Surgical Society,
Seoul, South Korea,
2025/11
|
|
3.
|
◎Hiroyuki Ishida：
Portomesenteric Venous Thrombosis after Pancreatic Cancer Surgery with Venous Resection and Reconstruction: Timing, Incidence, and Risk Factors.
Annual Congress of KSS 2025 & 77th Congress of theKorean Surgical Society,
Seoul, Korea,
2025/11
|
|
4.
|
◎Hroyuki Ishida：
Surgery for Pancreatic Cancer with Superior Mesenteric Artery Involvement after Neoadjuvant Therapy.
Annual Congress of KSS 2025 & 77th Congress of theKorean Surgical Society,
Seoul, Korea,
2025/11
|
|
5.
|
◎Sohei Satoi：
The Beneficial Role of Surgery for Metastatic Pancreatic Cancer after Systemic Therapy.
Annual Congress of KSS 2025 & 77th Congress of theKorean Surgical Society,
Seoul, South Korea,
2025/11
|
|
6.
|
◎Yuto Nishidono, Tetsuya Okuyama, Richi Nakatake, Mikio Nishizawa, Ken Tanaka, Hiroaki Hayashi：
Three new kavalactone derivatives from Alpinia zerumbet pericarps.
The 56th International Congress of KSP & 13th KSP-JSP-CPA Joint Symposium.,
Seoul, Korea,
2025/11
|
|
7.
|
◎Sohei Satoi：
Biological Resectability in Pancreatic Adenocarcinoma Is There Role for Surgery in Metastatic Patients?.
American College of Surgeons2025,
Chicago,
2025/10
|
|
8.
|
◎Masamichi Hayashi, Tomohisa Yamamoto, Masamichi Mizuma, Katsuhisa Hirano, Atsushi Oba, Toshimichi Asano, Hideyo Miyato, Makoto Yoshida, Hideki Takami, So Yamaki, Daisuke Hashimoto, Yasutoshi Kimura, Satoshi Hirano, Yosuke Inoue, Tsutomu Fujii, Michiaki Unno, Yasuhiro Kodera, Joji Kitayama, Sohei Satoi.：
Clinical impact of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: a multicenter retrospective study in Japan.
ESMO Gastrointestinal Cancers Congress 2025,
Barcelona,Spain,
2025/07
|
|
9.
|
◎Daisuke Hashimoto：
Neoadjuvant treatment targeting CA19-9 for resectable/borderline resectable pancreatic ductal adenocarcinoma.
The 2nd Annual Meeting of the Chinese Association of Panc reatology,
Chongqing, China,
2025/06
|
|
10.
|
◎Sohei Satoi：
Pancreatic Surgery for Pancreatic Ductal Adenocarcinoma ～ JAPAN Evidence ～.
SOUTHERN BRAZILIAN CONGRESS OF DIGESTIVE DISEASES 2025,
Barcelona,Spain,
2025/05
|
|
11.
|
◎Thanh Sang Nguyen,Hidetaka Miyazaki, Daisuke Hashimoto, Mitsuaki Ishida, So Yamaki, Kazuki Matsumura, Yuki Matsui, Tsybulskyi Denys, Yoshinobu Hirose, Sohei Satoi：
A novel method to analyze residual tumor in UR-PDAC who underwent conversion surgery.
pancreas club meeting,
San Diego,
2025/05
|
|
全国規模の学会
|
|
1.
|
◎三井哲史、池田裕二、松井雄基、Nguyen Thanh Sang、宮崎秀高、石田啓之、松村和季、山木 壮、橋本大輔、里井壯平：
手術ハイリスク患者に対する急性胆嚢炎の手術成績.
第117回大阪胆道疾患研究会,
大阪,
2026/03
|
|
2.
|
◎平野貴久、橋本大輔、山木 壮、松村和季、三井哲史、石田啓之、宮崎秀高、松井雄基、池田裕二、Nguyen Thanh Sang、里井壯平：
膵臓・脾臓 膵頭十二指腸切除術後の再入院危険因子と至適な在院期間の検討.
第209回近畿外科学会,
大阪,
2026/02
|
|
3.
|
◎宮崎秀高 橋本大輔 池田裕二 松井雄基 石田啓之、三井哲史 松村和季、山木壮、里井壯平：
切除不能膵癌に対するConversion Surgeryの長期成績及び、予後解析.
第124回日本消化器病学会近畿支部例会,
大阪,
2026/01
|
|
4.
|
◎中竹利知、奥山哲矢、北出浩章、里井壮、,石崎守彦、三井智史、安河内彦、日笠幸一郎.：
肝切除術術中の肝虚血再灌流障害に対する機能性食品AHCC®の臓器保護効果検討- bedside to bench-.
機能性食品国際学会 第33回年会,
札幌,
2025/11
|
|
5.
|
◎奥山哲矢、中竹利知、柳田英佐、北出浩章、里井壯平、石崎守彦、西澤幹雄.：
患者由来の初代培養肝細胞を用いたECLM（AHCC®）の肝障害抑制機構の解析：基礎的知見に基づく臨床応用の展望統合医療.
機能性食品国際学会 第33回年会（ICNIM2025）,
札幌,
2025/11
|
|
6.
|
◎西殿悠人、田中謙、林宏明、奥山哲矢、中竹利知、西澤幹雄.：
LC/MSを用いたゲットウ（月桃）からのカヴァラクトン類の探索と構造決定.
機能性食品国際学会 第33回年会（ICNIM2025）,
札幌,
2025/11
|
|
7.
|
◎宮崎秀高、橋本大輔、松井雄基、松村和季、山木壮、里井壯平：
AHCC（機能性食品）投与による切除不能膵癌の治療成績改善を探索的に検討するための多施設共同第II相試験.
統合医療機能性食品国際学会 第33回年会,
札幌,
2025/11
|
|
8.
|
◎橋本大輔、山木壮、松村和季、宮崎秀高、松井雄基、池田裕二、Denys Tsybulskyi、Nguyen Thanh Sang、里井壯平：
AHCC（機能性食品）投与による切除可能・境界膵癌の治療成績改善を検証するための多施設共同二重盲検無作為化第II相比較試験.
統合医療機能性食品国際学会 第33回年会,
札幌,
2025/11
|
|
9.
|
◎松浦 徹, 足立成基, 那須厚則, 小中龍之介, 奥山哲矢, 中竹利知, 張野誉史, 山﨑 誠, 柳本泰明, 蔦 幸治：
低分子化ライチポリフェノールOligonol®を中心とした機能性食品の抗癌作用の患者由来癌オルガノイドを用いた検討.
統合医療機能性食品国際学会 第33回年会,
札幌,
2025/11
|
|
10.
|
◎橋本大輔、山木 壮、里井壯平：
膵癌非典型例に対する診断・治療のストランテジー CA19-9高値示すR/BRに対するchemotherapy switch.
第33回日本消化器関連,
神戸,
2025/11
|
|
11.
|
◎橋本大輔：
胆嚢癌を疑った時の落とし穴―炎症性病変・腫瘍性病変をどう見分けるか.
第61回日本胆道学会,
愛知,
2025/10
|
|
12.
|
◎橋本大輔：
胆嚢癌疑診例に対する治療戦略.
第61回日本胆道学会,
愛知,
2025/10
|
|
13.
|
◎水間正道、山本智久、林真路、平野勝久、大庭篤志、浅野賢道、宮戸秀世、吉田真誠、高見秀樹、山木壮、橋本大輔、木村康利、平野聡、井上陽介、藤井努、海野倫明、北山丈二、里井壯平：
Conversion surgery for pancreatic cancer with peritoneal metastasis.
第56回日本膵臓学会,
東京,
2025/07
|
|
14.
|
◎宮崎秀高、橋本大輔、池田裕二、松井雄基、松村和季、山木 壮、里井壯平：
膵癌において切除不能となる門脈浸潤とは何か？ 当院における門脈合併切除を伴う膵切除術の短期・長期成績について（＋非再建症例）.
第56回日本膵臓学会,
東京,
2025/07
|
|
15.
|
◎宮崎秀高、橋本大輔、池田裕二、松井雄基、松村和季、山木壮、里井壯平：
院における門脈合併切除を伴う膵切除術の短期・長期成績について（+非再建症例）.
第56回日本膵臓学会,
東京,
2025/07
|
|
16.
|
◎橋本大輔：
膵疾患臨床研究推進委員会セッション 肝転移を伴う膵癌に対するconversion surgeryの意義.
第56回日本膵臓学会,
東京,
2025/07
|
|
17.
|
◎橋本大輔、山木 壮、松村和季、宮崎秀高、松井雄基、池田裕二、Denys Tsybulskyi、Nguyen Thanh Sang、里井壯平：
Borderline resectable膵癌を再考する CA19-9を標的とする膵癌術前治療 -Biological borderline resectable時代の新しい治療strategy-.
第80回日本消化器外科学会,
神戸,
2025/07
|
|
18.
|
◎山田豪、橋本大輔、山木壮、大島健司、室谷健太、野本昴奨、砂川祐輝、大島由記子、中尾昭公、里井壯平：
Borderline resectable膵癌の再考-切除可能性分類とIAP基準から見た新たな治療戦略の提案.
第80回日本消化器外科学会,
神戸,
2025/07
|
|
19.
|
◎松井雄基：
膵癌腹膜播種に対する光免疫療法のターゲット探索と新規治療法の開発.
第80回日本消化器外科学会,
神戸,
2025/07
|
|
20.
|
◎池田裕二、山木壮、橋本大輔、松村和季、宮崎秀高、松井雄基、里井壯平：
自然縮小後2年で再増大を認めたSPNの1例.
第208回近畿外科学会,
神戸,
2025/07
|
|
21.
|
◎山木壮、橋本大輔、松村和季、宮崎秀高、松井雄基、池田裕二、里井壯平：
当科における腹腔鏡下脾温存膵体尾部切除術の手技と治療成績.
第80回日本消化器外科学会,
神戸,
2025/07
|
|
22.
|
◎北出浩章：
肝移植術後回復と極限環境への挑戦―移植患者さんとのキリマンジャロ登山.
第３７回日本脳死・蘇生学会,
枚方,
2025/06
|
|
23.
|
◎里井壯平：
膵癌に対する周術期栄養療法.
第37回日本肝胆膵外科学会,
軽井沢,
2025/06
|
|
24.
|
◎橋本大輔、山木 壮、松村和季、宮崎秀高、松井雄基、池田裕二、Denys Tsybulskyi、Nguyen Thanh Sang、里井壯平：
膵癌に対する術前化学療法の現状と展望 R/BR膵癌に対する術前治療におけるCA19-9を標的としたchemotherapy change.
第125回日本外科学会,
仙台,
2025/04
|
|
25.
|
◎元井冬彦、安次富裕哉、大庭篤志、杉浦禎一、橋本大輔、井上亨悦、岡田健司郎、高見秀樹、中村透、高橋良輔、赤星径一、田中公貴、大宮康次郎、大木克久、山木壮、水間正道、上村健一郎、菅原秀一郎、平野聡、里井壯平：
膵癌に対する術前化学療法の現状と展望 術前治療によるCA19-9 値減少の生存へ及ぼす影響：治療後CA19-9 値と減少率により定義される望ましい反応とは？.
第125回日本外科学会,
仙台,
2025/04
|
|
26.
|
◎松村和季、橋本大輔、山木壮、宮崎秀高、松井雄基、池田裕二、Denys Tsybulskyi 、Sang Nguyen Thanh 、里井壯平：
膵臓-低悪性度腫瘍-1 IPMN に対する膵切除術において術中膵管鏡は膵切離線決定に有用であるか.
第125回日本外科学会,
仙台,
2025/04
|
|
27.
|
◎松井雄基、橋本大輔、山木壮、松村和季、池田裕二、Denys Tsybulskyi 、Nguyen Thanh Sang、里井壯平、鈴木基史、花岡宏史：
膵臓-基礎-1 膵癌腹膜播種に対する光免疫療法のターゲット探索と新規治療法の開発.
第125回日本外科学会,
仙台,
2025/04
|
|
28.
|
◎Yuko Mimori-Kiyosue, Naoko Tokushige, Shoko Sakai, Akiko Hayashi, Richi Nakatake, Toru Matsu-ura, Tomoatsu Hayashi, Tetsu Akiyama, Yoshihiro Kawasaki：
HMMR identifies a Transit-Amplifying cell population with TA-specific mitotic behavior.
第84回日本癌学会学術総会,
金沢,
2025/09
|
|
29.
|
◎Yuko Mimori-Kiyosue, Naoko Tokushige, Shoko Sakai, Akiko Hayashi, Richi Nakatake, Toru Matsu-ura, Tomoatsu Hayashi, Tetsu Akiyama, Yoshihiro Kawasaki.：
HMMR identifies a Transit-Amplifying cell population with TA-specific mitotic behavior.
第84回日本癌学会学術総会,
金沢,
2025/09
|
|
30.
|
◎山木 壮、橋本大輔、松村和季、宮崎秀高、松井雄基、池田裕二、里井壯平：
Reconsidering clinical role of Conversion Surgery in pancreatic cancer Outcomes of CS for UR-PDAC and pathological grading using shrinkage patte.
第56回日本膵臓学会,
東京,
2025/07
|
|
31.
|
◎山木壮,橋本大輔,松村和季,宮崎秀高,松井雄基,池田裕二,里井壯平：
Outcomes of CS for UR-PDAC and pathological grading using shrinkage pattern.
第56回日本膵臓学会,
東京,
2025/07
|
|
32.
|
◎里井壯平：
Reconsidering clinical role of Conversion Surgery in pancreatic cancer.
第56回日本膵臓学会,
東京,
2025/07
|
|
33.
|
◎Daisuke Hashimoto, Tsukasa Ikeura, Kenichiro Uemura, Ippei Matsumoto, Yosuke Inoue, Satoshi Hirano, Masamichi Mizuma, Masayuki Sho, Tsutomu Fujii, Sohei Satoi, Yoshifumi Takeyama：
進行膵癌における術後早期再発回避のための集学的治療戦略 Multidisciplinary Treatment Strategies to Prevent Early Postoperative Recurrence in Advanced Pancreatic Cancer． High carbohydrate antigen 19-9 may predict early postoperative recurrence after conversion surgery for pancreatic ductal adenocarcinoma with liver metastasis -from a nationwide multicenter study-.
第37回日本肝胆膵外科学会,
軽井沢,
2025/06
|
|
34.
|
◎So Yamaki,Daisuke Hashimoto, Kazuki Matsumura, Hidetaka Miyazaki, Yuki Matusi, Yuji Ikeda, Thanh Sang Nguyen, Denys Tsybulskyi, Sohei Satoi：
Education, Training for HBP Surgery Securing young surgeons to achieve true work system reform ―Establishment of education system for young surgeon and reduction of workload―.
第37回日本肝胆膵外科学会,
軽井沢,
2025/06
|
|
35.
|
◎Thanh Sang Nguyen,Hidetaka Miyazaki, Daisuke Hashimoto, Mitsuaki Ishida, So Yamaki, Kazuki Matsumura, Yuki Matsui, Tsybulskyi Denys, Yaolin Xu, Yoshinobu Hirose, Sohei Satoi：
Pancreas, Conversion Pathological shrinkage patterns: a novel method to analyze residual tumor in UR-PDAC patients who underwent conversion surgery.
第37回日本肝胆膵外科学会,
軽井沢,
2025/06
|
|
36.
|
◎Sohei Satoi：
Morning seminar; “peri-operative nutritional support in patients with PDAC”.
第37回日本肝胆膵外科学会.,
軽井沢,
2025/06
|
|
37.
|
◎Kazuki Matsumura,Daisuke Hashimoto, Yuji Ikeda, Yuki Matsui, Hidetaka Miyazaki, So Yamaki, Denys Tsybulskyi, Sang Nguyen Thanh, Sohei Satoi：
Pancreas, Elderly Patients 1 Safe surgery and adjuvant chemotherapy are important for patients with pancreatic cancer aged 80 years or older.
第37回日本肝胆膵外科学会,
軽井沢,
2025/06
|
|
38.
|
◎Michinari Yamagishi,Daisuke Hashimoto, So Yamaki, Kazuki Matsumura, Hidetaka Miyazaki, Yuki Matsui, Yuji Ikeda, Denys Tsybulskyi, Thanh Sang Nguyen, Sohei Satoi：
Pancreas, Case 1 A case of spinal cord metastasis developed after resection for pancreatic ductal adenocarcinoma.
第37回日本肝胆膵外科学会,
軽井沢,
2025/06
|
|
39.
|
◎Yuji Ikeda,Sohei Satoi, Daisuke Hashimoto, So Yamaki, Kazuki Matsumura, Hidetaka Miyazaki, Yuki Matsui：
Pancreas, Case 1 A Case of Solid Pseudopapillary Neoplasm (SPN) with Natural Regression and Recurrence After Two Years.
第37回日本肝胆膵外科学会,
軽井沢,
2025/06
|
|
40.
|
◎Yuki Mtsui,Daisuke Hashimoto, So Yamaki, Kazuki Matsumura, Hidetaka Miyazaki, Yuji Ikeda, Tsybulskyi Denys, , Sohei Nguyen Thanh Sang,Satoi Sohei：
Biliary Tract, Laparoscopic Cholecystectomy 1 A history of gastrectomy is a risk factor for common bile duct stones in patients undergoing cholecystectomy: A single center retrospective study.
第37回日本肝胆膵外科学会,
軽井沢,
2025/06
|
|
その他
|
|
1.
|
◎Sohei Satoi：
Surgery for Metastatic Pancreatic Cancer.
First Annual International Rocky Mountain Pancreas Symposium,
Denver, Colorado.,
2025/04
|
|
2.
|
◎松村和季、山木 壮、宮崎秀高、松井雄基、池田裕二、橋本大輔、里井壯平：
導入期のロボット支援下膵尾部切除術（結腸癌術後単独脾転移の１例）.
第17回膵臓内視鏡外科研究会,
東京,
2025/11
|
|
3.
|
◎里井壯平：
腹腔鏡下/ロボット支援下膵切除における術中トラブルシューティング/忘れ得ぬ症例.
第17回膵臓内視鏡外科研究会,
東京,
2025/11
|
|
4.
|
◎里井壯平：
掴む・切る・止める 膵臓低侵襲手術での私の工夫.
第17回膵臓内視鏡外科研究会,
東京,
2025/11
|
|
5.
|
◎橋本大輔、池浦司、上村健一郎、松本逸平、井上陽介、平野聡、水間正道、庄雅之、藤井努、里井壯平、竹山宜典：
UR-M膵癌に対するConversion Surgeryの光と影 肝転移を伴うUR-M膵癌に対するConversion Surgery（日本膵臓学会プロジェクト研究から）.
第19回膵癌術前治療研究会,
大阪,
2025/10
|
|
6.
|
◎山木 壮、松村和季、橋本大輔、宮崎秀高、松井雄基、池田裕二、平野貴久、里井壯平：
８０歳以上の切除可能膵癌に対する術前化学療法の導入・完遂と予後の検討.
第19回膵癌術前治療研究会,
大阪,
2025/10
|
|
7.
|
◎平野貴久、橋本大輔、池田裕二、松井雄基、宮崎秀高、松村和季、山木 壮、里井壯平：
新規病理学的治療効果判定システム；切除可能/切除可能境界膵癌におけるpathological shrinkage.
第19回膵癌術前治療研究会,
大阪,
2025/10
|
|
8.
|
◎松井雄基、橋本大輔、山木壮、松村和季、宮崎秀高、池田裕二、Tsybulskyi Denys,Sang Nguyen、里井壯平、鈴木基史、花岡宏史、石田光明：
膵癌細胞に対するEpCAM-IR700を用いた光免疫療法の有用性.
第52回日本膵切研究会,
富山,
2025/08
|
|
9.
|
◎松村和季,橋本大輔,山木壮,宮崎秀高,松井雄基,池田裕二,Tsybulskyi Denys,NguyenThanh Sang,里井壯平：
当院でのPD教育方針.
第52回日本膵切研究会,
富山,
2025/08
|
|
10.
|
◎池田裕二、橋本大輔、山木壮、松村和季、宮崎秀高、松井雄基、里井壯平：
Multifocal IPMNの治療戦略.
第52回日本膵切研究会,
富山,
2025/08
|
|
11.
|
◎山木 壮、橋本大輔、松村和季、宮崎秀高、松井雄基、池田裕二、Denys Tsybulskyi、Nguyen Thanh Sang、里井壯平：
当科における膵体尾部切除術における膵切除方法ー手動ステープラーによる切離と超音波凝固切開装置による切離ー.
第52回日本膵切研究会,
富山,
2025/08
|
|
12.
|
◎里井壯平：
膵癌の集学的治療の進歩と将来展望.
別府県北消化器難治がん集学的治療研究会,
別府,
2025/06
|
|
13.
|
◎NGUYEN THANH SANG、宮崎秀高、橋本大輔、石田光明、山木壮、松村和季、松井雄基、池田裕二、Tsybulskyi Denys、XuYaolin、廣瀬善信、里井壯平：
Pathological shrinkage patterns: a promising method to evaluate prognosis in unresectable PDAC patients who underwent conversion surgery.
第52回日本膵切研究会,
富山,
2025/08
|
|
14.
|
◎里井壯平：
膵癌を早期にみつけるために～検診・診断・治療の最前線～ 膵癌の外科治療.
がん予防キャンペーン大2025,
大阪,
2025/10
|
|
15.
|
◎里井壯平：
AHCCの臨床応用；どんな患者さんに効果がある？.
第２回最適健康医療実践セミナー,
東京,
2025/07
|
|
16.
|
◎里井壯平：
膵癌の集学的治療の進歩と将来展望.
Current Oncology Seminars in Gifu2025,
岐阜,
2025/07
|
|
17.
|
◎里井壯平：
膵癌の集学的治療の進歩と将来展望.
メトロポリタン胆膵悪性腫瘍カンファレンス２０２５,
東京,
2025/07
|
|
18.
|
◎里井壯平：
膵癌の集学的治療の進歩と将来展望.
膵癌治療を考える会in Yamagata,
山形,
2025/06
|
|
